Janux Therapeutics Inc Financial Flexibility Index
Janux Therapeutics Inc financial flexibility index. Janux Therapeutics Inc (JANX) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-12.06 Million (operating CF $-12.34 Million minus capex $273.00K) represents 0% of total liabilities ($86.69 Million). Explore Janux Therapeutics Inc (JANX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Janux Therapeutics Inc (2019–2025)
Financial flexibility index of Janux Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Janux Therapeutics Inc across 7 annual periods. Check Janux Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Janux Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Janux Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Janux Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Janux Therapeutics Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.60x | $-81.19 Million | $-82.23 Million | $50.70 Million | ▼ -42.7% |
| 2024 | -1.12x | $-43.45 Million | $-43.81 Million | $38.73 Million | ▲ +17.0% |
| 2023 | -1.35x | $-48.73 Million | $-50.58 Million | $36.06 Million | ▼ -60.3% |
| 2022 | -0.84x | $-36.48 Million | $-42.92 Million | $43.27 Million | ▲ +26.6% |
| 2021 | -1.15x | $-15.49 Million | $-16.98 Million | $13.50 Million | ▼ -1126.9% |
| 2020 | -0.09x | $-2.89 Million | $-4.37 Million | $30.86 Million | ▲ +65.6% |
| 2019 | -0.27x | $-2.35 Million | $-3.83 Million | $8.62 Million | — |